Skip to main content
OpenTrials

Clinical trial condition

Opioid Use Disorder

Explore clinical trials studying Opioid Use Disorder. Study availability and eligibility vary by location and protocol.

380 public trials 128 recruiting studies
Refine in advanced search Browse all conditions

Opioid Use Disorder trial results

Completed

Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

NCT02537574

Conditions
Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations
  • North Country Clinical Research Oceanside, California, United States
  • NRC Research Institute Orange, California, United States
  • Atlantic Shores Hospital Lauderhill, Florida, United States
  • TRY Research Maitland, Florida, United States
View all 20 locations
View Trial Details
Completed

Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL

NCT02696434

Conditions
Behavior, Behavior, Addictive, Chemically-Induced Disorders, +7 more
Locations
  • Segal Institute for Clinical Research Lauderhill, Florida, United States
  • Research Centers of America, LLC Oakland Park, Florida, United States
  • Neuroscience Research Institute, Inc. Winfield, Illinois, United States
  • John Hopkins School of Medicine Baltimore, Maryland, United States
View Trial Details
Completed

Open-Label Treatment Extension Study

NCT02896296

Conditions
Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +4 more
Locations
  • Boyett Health Services Hamilton, Alabama, United States
  • Woodland International Research Group Little Rock, Arkansas, United States
  • Collaborative Neuroscience Network Long Beach, California, United States
  • Pacific Research Partners Oakland, California, United States
View all 29 locations
View Trial Details
Completed

Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder

NCT02510014

Conditions
Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +4 more
Locations
  • Haleyville Clinical Research Haleyville, Alabama, United States
  • Boyett Health Services Hamilton, Alabama, United States
  • Woodland International Research Group Little Rock, Arkansas, United States
  • Collaborative Neuroscience Network Garden Grove, California, United States
View all 42 locations
View Trial Details

Related conditions